abs119.txt	melanoma	is	the	most	aggressive	type	of	skin	cancer	in	the	united	states	with	anincreasing	incidence		melanoma	lesions	often	exhibit	high	immunogenicity		withinfiltrating	immune	cells	playing	important	roles	in	regression	of	tumorsoccurring	spontaneously	or	caused	by	therapeutic	treatment		computational	andexperimental	methods	have	been	used	to	estimate	the	abundance	of	immune	cells	intumors		but	their	applications	are	limited	by	the	requirement	of	large	gene	setsor	multiple	antibodies		although	the	prognostic	role	of	immune	cells	has	beenappreciated		a	systematic	investigation	of	their	association	with	clinicalfactors		genomic	features		prognosis	and	treatment	response	in	melanoma	is	stilllacking		this	study		identifies	a	25-gene	signature	based	on	rna-seq	data	fromthe	cancer	genome	atlas	(tcga)-skin	cutaneous	melanoma	(tcga-skcm)	dataset		thissignature	was	used	to	calculate	sample-specific	leukocyte	infiltration	scores(lis)	in	six	independent	melanoma	microarray	datasets	and	scores	were	found	tovary	substantially	between	different	melanoma	lesion	sites	and	molecularsubtypes		for	metastatic	melanoma		lis	was	prognostic	in	all	datasets	with	highlis	being	associated	with	good	survival		the	current	approach	provided	additionalprognostic	information	over	established	clinical	factors		including	age		tumorstage		and	gender		in	addition		lis	was	predictive	of	patient	survival	in	stageiii	melanoma		and	treatment	efficacy	of	tumor-specific	antigenvaccine	implications		this	study	identifies	a	25-gene	signature	that	effectivelyestimates	the	level	of	immune	cell	infiltration	in	melanoma		which	provides	arobust	biomarker	for	predicting	patient	prognosis		mol	cancer	res		1-11		Â©2018aacr	
